These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Is every case of muscle damage during hypolipemic therapy the side effect of this therapy? A case report]. Kedzia A; Krysiak R; Madej A; Okopień B Pol Arch Med Wewn; 2007 Oct; 117(10):473-6. PubMed ID: 18320790 [TBL] [Abstract][Full Text] [Related]
7. [Does hypothyroidism predispose muscular toxicity of fibrates?]. Tregouet B Rev Med Interne; 1991; 12(2):159. PubMed ID: 1853004 [No Abstract] [Full Text] [Related]
8. [Muscle pseudohypertrophy associated with hypothyroidism (Hoffman's syndrome)]. Benito-León J; Martín E; Méndez M; Miguélez R; Luna E; Cabello A Rev Neurol; 2001 May 16-31; 32(10):998-9. PubMed ID: 12809121 [No Abstract] [Full Text] [Related]
9. Kocher-Debré-Sémélaigne syndrome. Luiz N Indian Pediatr; 1998 Nov; 35(11):1115-6. PubMed ID: 10216548 [No Abstract] [Full Text] [Related]
11. Myopathy as the sole manifestation of thyroprivic hypothyroidism of autoimmune etiology. Wadhwa S J Assoc Physicians India; 2001 Oct; 49():1031-2. PubMed ID: 11848313 [No Abstract] [Full Text] [Related]
13. [Hoffmann's syndrome as an onset for us of hypothyroid myopathy]. Rodríguez-Garrocho A; Jover-Sáenz A; Barcenilla-Gaite F; Porcel-Pérez JM Med Clin (Barc); 2010 Jun; 135(2):92-3. PubMed ID: 19647278 [No Abstract] [Full Text] [Related]
19. [Hypothyroidism and muscular toxicity from fenofibrate, report of a case revealed by polymyositis]. Cherif O; Karma F; Ben Amor G; Kochbati S; Ben Amor B; Rokbani L Tunis Med; 1997 Feb; 75(2):87-91. PubMed ID: 9506029 [No Abstract] [Full Text] [Related]